These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8609251)

  • 1. Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
    Horn TD; Altomonte V; Vogelsang G; Kennedy MJ
    J Am Acad Dermatol; 1996 Mar; 34(3):413-7. PubMed ID: 8609251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
    Kennedy MJ; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Altomonte V; Huelskamp AM; Davidson NE
    J Clin Oncol; 1994 Feb; 12(2):249-57. PubMed ID: 8113833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.
    Kennedy MJ; Jones RJ
    Breast Cancer Res Treat; 1993; 26 Suppl():S31-40. PubMed ID: 8400331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
    van der Wall E; Horn T; Bright E; Passos-Coehlo JL; Bond S; Clarke B; Altomonte V; McIntyre K; Vogelsang G; Noga SJ; Davis JM; Thomassen J; Ohly KV; Lee SM; Fetting J; Armstrong DK; Davidson NE; Hess AD; Kennedy MJ
    Br J Cancer; 2000 Dec; 83(11):1405-11. PubMed ID: 11076645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of autocytotoxic T cells with cyclosporine and interferon-gamma for patients with non-Hodgkin's lymphoma after transplantation of peripheral blood stem cells.
    Nakao S; Miura Y; Zeng W; Takami A; Sugimori N; Yamazaki H; Yachie A; Shiobara S; Matsuda T
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S65-9. PubMed ID: 9440547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
    Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
    Bone Marrow Transplant; 1999 Sep; 24(6):637-40. PubMed ID: 10490729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation.
    Volc-Platzer B; Rappersberger K; Mosberger I; Hinterberger W; Emminger-Schmidmeier W; Radaszkiewicz T; Wolff K
    J Invest Dermatol; 1988 Aug; 91(2):162-8. PubMed ID: 3294303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR expression in epidermal keratinocytes after allogeneic bone marrow transplantation. Relationship to histology, rash, marrow purging, and systemic graft-versus-host disease.
    Sloane JP; Elliott CJ; Powles R
    Transplantation; 1988 Dec; 46(6):840-4. PubMed ID: 3061079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
    Kennedy MJ; Vogelsang GB; Beveridge RA; Farmer ER; Altomonte V; Huelskamp AM; Davidson NE
    J Clin Oncol; 1993 Mar; 11(3):478-84. PubMed ID: 8445424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
    Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
    Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
    Bolaños-Meade J; Garrett-Mayer E; Luznik L; Anders V; Webb J; Fuchs EJ; Huff CA; Matsui W; Borrello IM; Brodsky R; Kasamon YL; Swinnen LJ; Flinn IW; Ambinder RF; Jones RJ; Hess AD; Vogelsang GB
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1185-91. PubMed ID: 17889355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.
    Miura Y; Thoburn CJ; Bright EC; Chen W; Nakao S; Hess AD
    Blood; 2002 Oct; 100(7):2650-8. PubMed ID: 12239181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced autologous graft-versus-host disease for the treatment of cancer.
    Kennedy MJ
    Cancer Treat Rev; 1994 Jan; 20(1):97-103. PubMed ID: 8293430
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
    Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Santos GW
    Leuk Lymphoma; 1993 Oct; 11(3-4):215-20. PubMed ID: 8260896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease.
    Norton J; Sloane JP
    Transplantation; 1991 Jun; 51(6):1203-6. PubMed ID: 1675503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
    Wu JM; Bensen-Kennedy D; Miura Y; Thoburn CJ; Armstrong D; Vogelsang GB; Hess AD
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):455-64. PubMed ID: 15931634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery.
    Bauer DJ; Hood AF; Horn TD
    Arch Dermatol; 1993 Jul; 129(7):855-8. PubMed ID: 8323305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear chronic cutaneous graft-versus-host disease.
    Kikuchi A; Okamoto S; Takahashi S; Asano S; Nishikawa T
    J Am Acad Dermatol; 1997 Dec; 37(6):1004-6. PubMed ID: 9418777
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion.
    Stein M; Feldman E; Seiter K; Chiao JW; Goff H; Baskind P; Beer M; Ahmed T
    Bone Marrow Transplant; 1999 Nov; 24(10):1073-7. PubMed ID: 10578157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.